Epoprostenol sodium for treatment of pulmonary arterial.
Epoprostenol contains sodium Epoprostenol Sodium 0.5 mg Powder and Solvent for Solution for Infusion contains 2.4 mmol (or 54.7 mg) sodium per vial. To be taken into consideration by patients on a controlled sodium diet. If you think any of these apply to you, don’t take Epoprostenol until you have checked with your doctor.
Synthetic Api Epoprostenol Sodium,High Quality Cas 61849-14-7 Epoprostenol Sodium, Find Complete Details about Synthetic Api Epoprostenol Sodium,High Quality Cas 61849-14-7 Epoprostenol Sodium,Epoprostenol Sodium,High Quality Epoprostenol Na,Epoprostenol from Cardiovascular Agents Supplier or Manufacturer-Shandong Sunrise Technology Co., Ltd.
Prostacyclin (also called prostaglandin I2 or PGI 2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator. When used as a drug, it is also known as epoprostenol. The terms are sometimes used interchangeably.
Veletri 1.5mg, Powder for Solution for Infusion - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd. Epoprostenol Sodium, the monosodium salt of epoprostenol, a naturally occurring prostaglandin produced by the intima of blood vessels. Epoprostenol is the most potent inhibitor of platelet aggregation known.
The Epoprostenol Sodium Drugs market report has been prepared based on the synthesis, analysis, and clarification of information about the global Epoprostenol Sodium Drugs market from dedicated sources. The report is a collection of significant data related to the competitive landscape of the industry.
Technical details about Epoprostenol Sodium, learn more about the structure, uses, toxicity, action, side effects and more.
Epoprostenol (formerly known as prostacyclin or prostaglandin I 2) is a vasodilator which also inhibits platelet aggregation. In an eight-week randomised trial, 11 patients with primary pulmonary hypertension were given a continuous infusion of epoprostenol.